PATENT CLAIM ANALYSIS

Application Number: 15912421
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "516000"]

Abstract:
The present invention is directed to methods of treating, preventing, suppressing and/or inhibiting urological disorders such as urinary incontinence including stress urinary incontinence, urge urinary incontinence, mixed incontinence, and pelvic floor disorders by administering a SARM compound of the invention.

Claim (Index 12):
A method of reducing the occurrence or lessening the severity of at least one of the following symptoms in a postmenopausal female subject suffering from stress urinary incontinence, urge urinary incontinence or a combination thereof: (i) average daily frequency of urination; (ii) average nightly frequency of urination; (iii) total urinary incontinence episodes; (iv) stress incontinence episodes; and (v) urinary urgency episodes; comprising administering a SARM compound of Formula IX: or its isomer, hydrate, pharmaceutically acceptable salt, pharmaceutical composition or any combination thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 1.35294
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15190732', '15786811', '15887076', '14168993', '13627900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7633425630081017
- 35 USC 102 Novelty (BERT): 0.5328614816193529
- Combined Prediction Score: 0.7402944548692268
- Mean Citation Score: 350.786358
- Max Citation Score: 363.79123
- Similarity Product: 226.9211659802252

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test